Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on April 7, 2025

HeartCore Announces Strategic Partnership with NEC Solution Innovators, Ltd. to Enhance CMS Implementation Process

HeartCore Announces Strategic Partnership with NEC Solution Innovators, Ltd. to Enhance CMS Implementation Process

NEW YORK and TOKYO, April 07, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced a strategic partnership with NEC …

3D Systems Transforming Manufacturing with Application-specific Solutions at RAPID+TCT 2025

3D Systems Transforming Manufacturing with Application-specific Solutions at RAPID+TCT 2025

Reduce cost of high mix, low volume manufacturing by multiple orders of magnitude with high-throughput, precision Figure® 4 135 solution Achieve up to 60% improved process efficiency for applications such as jigs and fixtures, tooling, …

Red Cat Appoints Shawn Webb as President of FlightWave Aerospace

Red Cat Appoints Shawn Webb as President of FlightWave Aerospace

SANTA MONICA, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today …

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …

SEALSQ and WISeSat to Showcase Breakthrough Post-Quantum Satellite Technology at the 40th Annual Space Symposium in Colorado Springs

SEALSQ and WISeSat to Showcase Breakthrough Post-Quantum Satellite Technology at the 40th Annual Space Symposium in Colorado Springs

Geneva, Switzerland, April 07, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, together with …

LIS Technologies Inc. to Attend the World Nuclear Fuel Cycle 2025 Conference with Co-Founder and CEO Christo Liebenberg Scheduled to Present

LIS Technologies Inc. to Attend the World Nuclear Fuel Cycle 2025 Conference with Co-Founder and CEO Christo Liebenberg Scheduled to Present

Oak Ridge, Tennessee, April 07, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that its …

DeflationCoin Launches to Fix Bitcoin’s Flaws with Burn-Based Model and Smart Staking

DeflationCoin Launches to Fix Bitcoin’s Flaws with Burn-Based Model and Smart Staking

Dubai, UAE, April 07, 2025 (GLOBE NEWSWIRE) -- DeflationCoin formally launched a groundbreaking cryptocurrency with the purpose of fixing the economic and technological shortcomings of Bitcoin and Ethereum.  The team is introducing a hard cap on the total …

Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center

Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center

RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced the successful completion of …

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize development pathways. NAPLES, Fla. and CAMBRIDGE, United …

Montage Gold Closes First Tranche of Investment in African Gold

Montage Gold Closes First Tranche of Investment in African Gold

VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Montage Gold Corp. (“Montage” or the “Company”) (TSXV: MAU, OTCQX: MAUTF) is pleased to announce the closing of the first tranche of its previously announced strategic investment in African …

Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations

Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations

ASHBURN, Va., April 07, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), an authorized enrollment provider, continues to expand locations to enroll consumers in the TSA PreCheck® program by opening 10 new locations in California, Florida, Hawaii, …

American Rebel Holdings Issues Corporate Update Highlighting Recent Key Milestones and Strategic Growth Initiatives

American Rebel Holdings Issues Corporate Update Highlighting Recent Key Milestones and Strategic Growth Initiatives

Forged in Freedom, Fueled by Growth, Focused on the Future NASHVILLE, TN, April 07, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), the creator of American Rebel Beer (americanrebelbeer.com) and a …

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who completed 17 doses improved from moderate to mild AD within just 3 …

Crypto Investors Turn to Hartcoin for Trusted FREE Bitcoin Mining Platforms

Crypto Investors Turn to Hartcoin for Trusted FREE Bitcoin Mining Platforms

London, UK, April 07, 2025 (GLOBE NEWSWIRE) -- Hartcoin, an innovative cryptocurrency cloud mining platform, is redefining how crypto enthusiasts mine Bitcoin and other cryptocurrencies. With a commitment to flexibility, profitability, and security,  …

reAlpha Tech Corp. Announces Exercise of Warrants for $3.1 Million Gross Proceeds

reAlpha Tech Corp. Announces Exercise of Warrants for $3.1 Million Gross Proceeds

DUBLIN, Ohio, April 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, today announced the entry into …

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine …

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

CARMEL, Ind., April 07, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, …

HII Delivers Initial Lionfish SUUVs to U.S. Navy Under Multi-Year Program

HII Delivers Initial Lionfish SUUVs to U.S. Navy Under Multi-Year Program

POCASSET, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced the delivery of first two Lionfish small uncrewed undersea vehicles (SUUVs) to the U.S. Navy under a program that could scale to 200 vehicles, with a contract value exceeding $ …

CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea

CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea

EDGEWOOD, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced today that they completed production and delivery of an Airborne Laser Mine Detection System (ALMDS) pod structure for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service